Sonnet BioTherapeutics Holdings, Inc. (SONN) EPS by Year
SONN
Sonnet BioTherapeutics Holdings, Inc. lost $3.95 per diluted share in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sonnet BioTherapeutics Holdings, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More Sonnet BioTherapeutics Holdings, Inc. financials
What was Sonnet BioTherapeutics Holdings, Inc.'s diluted earnings per share in fiscal year 2025?
Sonnet BioTherapeutics Holdings, Inc. lost $3.95 per diluted share in fiscal year 2025.
What was Sonnet BioTherapeutics Holdings, Inc.'s diluted earnings per share in the most recent quarter?
Sonnet BioTherapeutics Holdings, Inc. (SONN) reported -$0.79 in diluted earnings per share in Q4 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Sonnet BioTherapeutics Holdings, Inc. (SONN) reported on that line in every period on record.
